A parsimonious model to validate cost-effectiveness analyses on preventive health care
Abstract Background The effect of preventive health care on health expenditures is ambiguous. On the one hand, prevention reduces the costs of future morbidity. On the other hand, prevention leads to costs of life extension. The purpose of this paper is to develop a parsimonious model that determine...
Enregistré dans:
Auteur principal: | Afschin Gandjour |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4f08b99094b34d8cb8e560e7068a0bc4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
par: Michał Pochopień, et autres
Publié: (2021) -
Cost analysis of informal care: estimates from a national cross-sectional survey in Sweden
par: Björn Ekman, et autres
Publié: (2021) -
Economic evaluation of advanced practice physiotherapy models of care: a systematic review with meta-analyses
par: Simon Lafrance, et autres
Publié: (2021) -
Validity and reliability of the Chinese version of the partners at care transitions measure
par: La-mei Liu, et autres
Publié: (2021) -
Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study
par: Yue Ma, et autres
Publié: (2021)